Valuation IMPACT Therapeutics, Inc

Stocks

Market Closed - Hong Kong S.E. 08:08:07 26/10/2026 GMT			5-day change	1st Jan Change
10.85 ^HKD	+4.23%		-11.28%	-

10-23	Impact Therapeutics Presents Results from Three Tumor Drug Studies at European Oncology Meeting	MT
09-18	IMPACT Therapeutics And Pharmanovia Receive Positive CHMP Opinion For Senaparib As First-Line Maintenance Treatment Of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, And Primary Peritoneal Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	2,501	-	-
Change	-	-	-
Enterprise Value (EV) ¹	1,685	1,495	1,373
Change	-	-11.24%	-8.2%
P/E	-	-	-
PBR	-	-	-
PEG	-	-	-
Capitalization / Revenue	9.45x	3.97x	3.61x
EV / Revenue	6.36x	2.37x	1.98x
EV / EBITDA	-12x	12.3x	21.6x
EV / EBIT	-11.7x	12.6x	22.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-	-	-
Distribution rate	-	-	-
Net sales ¹	264.8	629.6	692
EBITDA ¹	-140.7	121.4	63.66
EBIT ¹	-144.2	118.4	59.97
Net income	-	-	-
Net Debt ¹	-816.4	-1,006	-1,128
Reference price ²	8.854	8.854	8.854
Nbr of stocks (in thousands)	282,462	-	-
Announcement Date	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMPACT THERAPEUTICS, INC	-	8.02x	-15.09x	-	375M
WUXI APPTEC CO., LTD.	18.83x	6.63x	13.18x	1.58%	64.69B
ARGENX SE	30.16x	8x	26.2x	0.05%	54.78B
LONZA GROUP AG	36.79x	6.53x	19.51x	0.88%	53.49B
IQVIA HOLDINGS INC.	35.59x	3.45x	14.87x	-.--%	45.98B
BEONE MEDICINES AG	49.71x	5.74x	31.52x	-.--%	42.94B
REVOLUTION MEDICINES, INC.	-19.41x	187.75x	-20.66x	-.--%	40.08B
CELLTRION, INC.	28.93x	8.21x	21.27x	0.37%	33.52B
WUXI BIOLOGICS (CAYMAN) INC.	27.67x	5.83x	15.12x	-.--%	23.97B
GENMAB A/S	32.59x	5.97x	20.28x	-.--%	23.67B
Average	26.76x	24.61x	12.62x	0.32%	38.35B
Weighted average by Cap.	26.72x	25.31x	15.88x	0.43%